Portfolio company
Aclara Biosciences
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops microfluidic lab-on-a-chip technology for genomics, drug screening and clinical diagnostics applications for pharmaceutical companies and laboratory researchers.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Finnadvance
This company develops microfluidic organ-on-chip platforms for pharmaceutical and academic researchers to perform drug testing and mimic human organ functions.
Nanocellect Biomedical
This company develops microfluidic cell sorting instruments and consumables for biomedical researchers in drug discovery, genomics and cell line development.
Parallel Fluidics
This company manufactures custom microfluidic devices and automated fluid processing units for life science researchers and biopharmaceutical laboratories.
Fluid Screen
This company develops lab-on-a-chip systems to detect and identify bacterial contamination in fluids for biotherapeutics manufacturers, healthcare providers and water quality monitoring services.
Lightcast Bio
This company develops a microfluidic platform for single-cell functional analysis for pharmaceutical companies and academic research institutions.
Stokes Bio
This company develops microfluidic systems for genetic analysis and molecular diagnostics, serving life science researchers and pharmaceutical organisations.
Plexigen
This company develops biochips and instrumentation for genomic and proteomic testing to serve clinical research and diagnostic laboratories.
ScreenIn3D Limited
This company develops microfluidic lab-on-a-chip platforms for drug developers to test therapies on patient-derived three-dimensional tumour samples.
